Group Wants FDA Leaders Ousted Over Alzheimer's Drug Approval
Advocates Who Backed Approval Decry Cost Aducanumab had a rocky road to approval but had unwavering backing from the Alzheimer’s Association and at least one other organization, UsAgainstAlzheimer’s. The Alzheimer’s Association was particularly outspoken in its support, and, as reported by Medscape in March, was accused of potential conflict of interest by […]